# Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride

NDC: 58602-703
Generic name: Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
Labeler / Manufacturer: Aurohealth LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20230308

FDA application: ANDA212409

## Active ingredients

- CETIRIZINE HYDROCHLORIDE: 5 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE: 120 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58602-703"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58602-703
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26f2c3c1-a2f2-474a-950a-8cfe07f289fa